PEAK6 Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,890
Closed -$155K 3612
2024
Q2
$214K Buy
+1,890
New +$239K ﹤0.01% 2717
2024
Q1
Sell
-39,782
Closed -$5M 4190
2023
Q4
$4.94M Sell
39,782
-6,762
-15% -$691K 0.02% 855
2023
Q3
$4.34M Buy
+46,544
New +$5.25M 0.02% 798
2022
Q2
Sell
-8
Closed -$730 6181
2022
Q1
$1K Buy
+8
New +$875 ﹤0.01% 5012
2021
Q4
Sell
-8
Closed -$1.15K 5252
2021
Q3
$1K Sell
8
-8
-50% -$1.01K ﹤0.01% 4982
2021
Q2
$2K Sell
16
-12,428
-100% -$1.19M ﹤0.01% 4900
2021
Q1
$1.12M Buy
+12,444
New +$1.17M ﹤0.01% 2438
2020
Q4
Sell
-21,856
Closed -$1.95M 4692
2020
Q3
$2.25M Buy
+21,856
New +$2.28M 0.01% 1560
2020
Q2
Sell
-42,240
Closed -$3.78M 4471
2020
Q1
$2.84M Buy
+42,240
New +$2.63M 0.02% 812

Other funds holding DXCM

PEAK6 Investments's DXCM Position: Q3 2024 in Review

PEAK6 Investments sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,890 shares — an estimated $155K sold.

PEAK6 Investments first reported a position in DXCM in Q1 2020 and held it in 9 quarters. The position peaked at $4.94M in Q4 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • PEAK6 Investments reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 1,890 DexCom shares in Q3 2024, an estimated $155K.
  • PEAK6 Investments first reported a position in DexCom in Q1 2020 and held it in 9 quarters.
  • PEAK6 Investments's DexCom position peaked at $4.94M in Q4 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.